Evidence map›Paper›PMID 36536754›Full record

ReviewPatient related outcome measures2022

A Systematic Review of Patient Engagement Experiences in Brain Disorders.

Deborah Bertorello, Giampaolo Brichetto, Frans Folkvord, Alexandra Theben, Paola Zaratin

Open access · goldAbstract readReview
In one paragraph

Review in Patient related outcome measures, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Deborah BertorelloItalian Multiple Sclerosis Society Foundation, Genoa, Italy.
Giampaolo BrichettoItalian Multiple Sclerosis Society Foundation, Genoa, Italy.
Frans FolkvordOpen Evidence Research, Barcelona, Spain.
Alexandra ThebenDepartment of Management, Humanities, Law and Society, UPF-Barcelona School of Management, Barcelona, Spain.
Paola ZaratinItalian Multiple Sclerosis Society Foundation, Genoa, Italy.
Associazione Italiana Sclerosi Multipla · ITOpen Evidence · ESUPF Barcelona School of Management

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patient engagement is increasingly considered to be an important element in the treatment of brain disorders to optimise outcomes for patients, society, and healthcare systems. Nonetheless, scientific research examining methodologies to engage patients with brain diseases in Research and Innovation (R&I) is scarce. Aim: To review existing scientific evidence regarding the engagement of patients with brain disorders in research and innovation. Methods: Studies were retrieved from several bibliographic databases (publication date between January 2016 and April 2019) with pre-specified selection criteria. Results: In total, 49 articles were identified as meeting the inclusion criteria and were reviewed systematically. Results showed that there is limited evidence available on the impact and (cost-) effectiveness of patient engagement in (brain) research and innovation. Most published studies are protocols, guidelines, and discussion articles for patient engagement in health research and innovation. Overall, there exists a general consensus to engage patients in every step of the research procedure. Relevant evidence identified includes principles of engagement, definitions of stakeholder types, key considerations for planning, conducting and disseminating engaged research, potential engagement activities, and examples of promising practices. Discussion: Findings are inconclusive due to methodological differences. Comparison between studies was difficult due to differences in patients, form of engagements, and total duration of engagement of patients. Experiences of patient engagement mainly concern adherence to medical treatments or participation of "expert patients" in clinical trials, but very rarely the governance of R&I according to the dictates of Responsible Research and Innovation (RRI). More structuralized, well-conducted and comparable Randomized Controlled Trials (RCTs) are needed to be able to make evidence-based recommendations on how to increase effective patient engagement in research and innovation and assess the impact and (cost)-effectiveness.

Indexed as

brain disorderspatient engagementpatient reported outcomesresponsible research and innovationsystematic review

Identifiers

PMID36536754
PMCPMC9758979
OpenAlexW4311230340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.